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Abstract Anchoring proteins to cell surface membranes by
glycosylphosphatidylinositols (GPIs) is important. We have
isolated a component of the putative transamidase machinery,
hGaa1p (human GPI anchor attachment protein). hGAA1 cDNA
is approximately 2 kb in length and codes 621 amino acids. The
amino acid sequence of hGaa1p is 25% identical and 57%
homologous to that of yeast Gaa1p. Moreover, Kite-Dolittle
hydrophobicity plots of both proteins show marked similarity.
hGAA1 gene is expressed ubiquitously and mRNA levels are
higher in the undifferentiated state. Overexpression of antisense
hGAA1 in human K562 cells significantly reduced the production
of a reporter GPI-anchored protein.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Posttranslational glycosylphosphatidylinositol (GPI) anchor
attachment serves as a general mechanism for linking proteins
to the cell surface membrane [1^3]. The mechanism of mam-
malian GPI biosynthesis has been studied using mutant cells
that are defective in di¡erent steps of the biosynthetic path-
way. Important among these mutants have been GPI-defec-
tive murine T-cell lymphomas selected by their inability to
express Thy-1 on their surfaces [4]. These mutants, grouped
into di¡erent complementation classes, A, B, C, E, F, and H,
transcribe the Thy-1 gene normally but retain Thy-1 protein
intracellularly. Classes A, C, and H are all defective in the ¢rst
step, synthesis of N-acetylglucosaminyl phosphatidylinositol
[5,6]. Class E is not able to synthesize dolichol-phosphoryl-
mannose, the mannose donor for GPI synthesis [6,7]. Class B
cannot incorporate distal K1-2-linked mannose into the glycan
core [6] and class F is unable to add terminal ethanolamine
phosphate to this third mannose residue [5,6,8]. Additional
complementary mutant lines representing other steps have
been N-methyl-NP-nitro-N-nitrosoguanidine (MNNG) treated
human K562 erythroleukemic cell mutants, classes J and K
[9,10]. Class J is defective at the second step, deacetylation of
N-acetyl-D-glucosamine-inositol phospholipid to glucosamine-
inositol phospholipid [10]. Recently, two other mutants of
Chinese hamster ovary cells having defects in the same second
step were reported [11,12]. One was designated class L. Class
L may be identical to class J. Many of the genes responsible
for these defects have been isolated including PIG (phospha-
tidyl inositol glycan)-A [13], PIG-B [14], PIG-C [15], PIG-F
[16], PIG-H [17], and PIG-L [12]. In contrast to the above
mutants all of which are defective in GPI assembly, in the
class K mutant, the complete GPI precursor is formed, but
a defect in the substitution of GPIs for COOH-terminal signal
sequences is responsible for its inability to display GPI-an-
chored proteins [10,18].
As in mammalian cells, a number of mutants in yeast which
cannot express GPI-anchored proteins have been described
and several of the a¡ected genes identi¢ed [19^21]. SPT14/
GPI3 and GPI2 are homologs of mammalian PIG-A [22]
and PIG-C [15], respectively. The yeast GAA1 (yGAA1) gene
has been isolated and characterized using a yeast GPI-an-
chored protein de¢cient mutant termed gaa1 [23]. gaa1 can
synthesize complete GPI precursors, but it cannot express
GPI-anchored proteins on the cell surface [23]. Another yeast
gene yGPI8 has been isolated from a second yeast mutant
termed gpi8 with a phenotype identical to that of gaa1 [24].
Thus gaa1 and gpi8 mutant cells have defects similar to mam-
malian class K mutant cells. Recent studies have shown that
mammalian class K mutant cells have a defect in the activity
of the transamidase [10,18]. The gene responsible for this de-
fect, i.e. the PIG-K gene, recently has been shown to corre-
spond to hGPI8 [25].
2. Materials and methods
2.1. The signal sequence trap method
Embryonic stem (ES) cells were A3.1 derived from the 129/SvJ
mouse strain [26]. poly (A) RNA was extracted from embryoid
bodies (EB) that had been di¡erentiated for 6 days. The signal se-
quence method was performed as described before [27]. In brief, 5P
termini-enriched EB cDNAs were ligated to the pcDL-SRK-Tac (3P)
vector in the same orientation with the Tac (K chain of the human
interleukin-2 receptor) cDNA to obtain an expression library. The
COS cells that were transfected by new secretory signal sequence
fusioned Tac plasmids expressed Tac fusion proteins on the cell sur-
face, and they were detected with anti-Tac antibody and FITC-con-
jugated second antibody. DNA sequences were determined on both
strands by the 373A DNA sequencer using the £uorescent dideoxy
terminator sequencing kit (Perkin Elmer). DNA sequences and de-
duced protein sequences were compared with sequences in the Gen-
Bank database for homology.
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Fig. 1. DNA and amino acid sequence of hGAA1. The nucleotide sequence of hGAA1 cDNA is shown with nucleotide positions indicated in
the right. The deduced amino acid sequence of hGAA1 is shown in single-letter code, with the amino acid numbers in the left. The putative
eight transmembrane domains are underlined. Two N-linked glycosylation sites are bold. A phosphorylation site by cAMP- and cGMP-depend-
ent protein kinase is bold and underlined. Protein kinase C phosphorylation sites are indicated with asterisks. Four leucins in leucin zipper pat-
tern are indicated by italic. A polyadenylation signal is doubly underlined. The GenBank, EMBL and DDBJ accession number is AB006969.
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Fig. 2. Comparison of hGaa1p and yGaa1p. A: Sequence comparison of human, murine and yeast Gaa1 protein. The amino acid numbers are
written in the right. Identical or homologous amino acids are enclosed by open boxes. Identical amino acids are indicated at the fourth lane as
consensus amino acids. B: Kyte-Dolittle hydrophobicity plots of hGaa1p and yGaa1p. Longitudial axis indicates hydrophobicity score. Hydro-
phobic and hydrophilic amino acids show positive and negative scores, respectively.
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2.2. Murine and human cDNA library screening
Approximately 1.0U106 plaques of murine heart cDNA library in
Uni-ZAP XR Vector (Stratagene) were screened. Plasmids were ex-
cised from phage vectors in vivo by the ExAssist helper phage. We
next screened human fetal heart cDNA library in Vgt11 (Clontech)
using murine GAA1 cDNA. Phage DNA was puri¢ed from isolated
clones, digested with EcoRI, and subcloned into pBluescript II SK
(Stratagene).
2.3. Northern blot analysis
Expression of hGAA1 mRNA in human tissues was examined using
Human fetal MTN blot and Human adult MTN blot (Clontech). The
¢lters were hybridized with 32P-labeled human GAA1 cDNA at 42‡C
for 12 h in 5USSPE, 50% formamide, 5UDenhardt’s solution, 4%
dextran sulfate, 0.5% SDS and 20 mg/ml heat denatured salmon
sperm DNA. The ¢lters were washed twice with 2USSC/0.1% SDS,
once with 1USSC/0.1% SDS and twice with 0.1USSC/0.1% SDS at
42‡C. Total RNA was extracted from embryoid bodies, rat fetal and
neonatal heart, and adult ventricle and atrium using RNAzolB (Bio-
tecx Laboratories). Twenty micrograms of total RNA were separated
on 1.0% formaldehyde-agarose gel and transferred to nylon mem-
brane ¢lters, Hybond-N. The ¢lters were hybridized with 32P-labeled
murine GAA1 cDNA.
2.4. Transient transfection of K562 cells
We subcloned a full length hGAA1 cDNA into pCDNA3 vector
(Invitrogen) in both directions. K562 cells (6U106 at 5^8U105/ml)
were incubated overnight in RPMI 1640 containing 10% heat inacti-
vated newborn calf serum, washed twice with serum-free RPMI 1640,
and readjusted to 5U106/ml. One milliliter of washed cells was inocu-
lated with 1 MOI/cell of VTF7.3 virus in RPMI 1640 containing 2%
newborn calf serum, and the cells infected for 1 h by shaking at 15
min intervals at 37‡C. Infected cells were washed with serum-free
RPMI followed by HeBS transfection bu¡er, and after adjustment
to 106 cells in 0.8 ml of HeBS, 30 Wg of CD8-DAF/pCDNA1 and
10 mg salmon sperm DNA were added with or without 10 Wg of the
test plasmid. The mixture was incubated on ice for 10 min and the
DNA introduced by electroporation at 250 V and 960 mF in a Gene-
Pulser (Bio-Rad Laboratories). Electroporated cells were cultured in
complete RPMI 1640. After 48 h they were stained with anti-CD8
mAB/FITC-conjugated anti-mouse Ig and propidium iodide and an-
alyzed on a FACStarPlus (Becton Dickson) £ow cytometer.
3. Results
3.1. Isolation of signal sequence containing proteins from an
EB library
By screening 7800 clones, we obtained 36 positive plasmids
from the EB library by the signal sequence method. All pos-
itive clones were sequenced and their sequences were searched
for in the GenBank database. The deduced amino acid se-
quence of one clone, 82D3, showed no homologies to any
known sequences except yGaa1p.
3.2. Isolation and sequencing of human GAA1 cDNA
With the use of 82D3 cDNA we screened a murine heart
cDNA library and obtained two full length murine GAA1
cDNAs which we termed M1 and M2 (data not shown). Us-
ing M1 we next screened a human heart cDNA library and
obtained three clones which we termed H1, H10, and H18.
Nucleotide sequences of the three cDNAs were determined
and the analysis revealed that H18 encompassed a 1.6 kb
fragment of the 5P-terminal region and H1 an overlapping
1.5 kb fragment of the 3P-terminal region of an overall human
cDNA corresponding to murine GAA1 cDNA. H10 over-
lapped the central 1.0 kb region of H1. A composite cDNA
designated H118 was prepared by digesting H1 and H18 with
EcoRV and ligating them. It is approximately 2 kb in length
(Fig. 1), a size almost the same as that of mRNA detected in
Northern blot analysis. The sequence around the predicted
translation initiation site (CGCCATGGG) is consistent with
the Kozak consensus sequence. The H118 cDNA sequence
has a long open reading frame consisting of 621 amino acids.
In the 3P-terminal untranslated region, there is a polyadeny-
lation signal (AATAAA) 17 bp upstream of the poly (A)
tract. Computer analysis showed that the deduced protein
has a 47 amino acid secretory signal sequence at the NH2
terminus, one cAMP- and cGMP-dependent protein kinase
phosphorylation site, one leucine zipper pattern, two putative
N-glycosylation sites, and eight putative transmembrane do-
mains.
The overall deduced amino acid sequence shows signi¢cant
homology with that of yGaa1p (Fig. 2A). The translated
H118 cDNA sequence is 25% identical and 57% homologous
to that of yGaa1p. Moreover, the Kite-Dolittle hydrophobic-
ity plot of the deduced protein corresponds closely to that of
yGaa1p (Fig. 2B). We thus named this human cDNA as
hGAA1 (human GAA1).
3.3. Expression of hGAA1
We examined expression of hGAA1 mRNA in various tis-
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sues of the human fetus and adult. A single band of V2 kb in
length was detected in all tissues of the human fetus (Fig. 3A)
and adult (Fig. 3B) that were examined. Expression levels
were generally higher in fetal than in adult tissues. We next
examined alterations of expression levels of rodent GAA1
mRNA during development. In rats, GAA1 mRNA was abun-
dantly expressed in the fetal and neonatal hearts as compared
with the adult heart (Fig. 4A). When ES cells are cultured in
suspension without LIF, they develop into EB and ¢nally
various cell types including cardiac myocytes and hemato-
poietic cells [28]. This in vitro di¡erentiation system re£ects
the in vivo situation and is useful to examine the very early
stage of the embryo [29]. In EB, mRNA levels were high in
the undi¡erentiated state and gradually decreased with devel-
opment (Fig. 4B).
3.4. Transient transfection of K562 cells
To examine whether hGaa1p functions in GPI anchoring,
we transfected antisense hGAA1 cDNA into K562 cells with
the GPI-anchored protein reporter cDNA, CD8-DAF (Table
1). At the ¢rst experiment, the percentage of GPI-anchored
CD8 positive cells following transfection with CD8-DAF/
pCDNA1 was 4.10 þ 0.35 (Fig. 5, upper two panels). Over-
expression of antisense hGAA1 cDNA strongly inhibited this
expression to less than half (1.64 þ 0.07) of control levels (Fig.
5, lower two panels). A second experiment was performed
using both antisense and sense hGAA1 cDNA. Overexpression
of sense hGAA1 cDNA had a small but not signi¢cant e¡ect
on the expression of GPI-anchored CD8, but overexpression
of antisense cDNA again signi¢cantly decreased it (control,
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Fig. 4. Expression of GAA1 mRNA in the developmental stage. A:
Northern blot analysis of rat GAA1 in rat fetal and neonatal heart
and adult ventricle and atrium. B: Northern blot analysis of murine
GAA1 in undi¡erentiated embryonic stem cells and di¡erentiated
embryoid bodies. Twenty micrograms of total RNA were hybridized
with 32P-labeled murine cDNA probe.
Fig. 3. Expression of GAA1 mRNA in various tissues. Northern
blot analysis of hGAA1 in human fetal (A) and adult (B) tissues
(human fetal and adult MTN blot). Two micrograms of poly (A)
RNA isolated from various human fetal and adult tissues were hy-
bridized with 32P-labeled hGAA1 cDNA probe.
Table 1
Percent GPI-anchored CD8 positive cells
Experiment
1 2 3
Antisense 1.64 þ 0.07 3.40 þ 0.7 10.33 þ 0.2
Control 4.10 þ 0.35 6.50 þ 0.07
Sense 7.30 þ 1.0 15.10 þ 2.7
In all experiments, antisense hGAA1 cDNA signi¢cantly decreased the
percent of GPI-anchored CD8 positive cells.
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6.50 þ 0.07; antisense, 3.40 þ 0.07). A third experiment using
sense and antisense constructs reproduced the inhibitory e¡ect
of antisense hGAA1 cDNA (sense, 15.10 þ 2.27; antisense,
10.33 þ 0.20). These results indicate that hGaa1p functions
in GPI anchoring presumably acting at the GPI transfer
step as has been shown for yGaa1p.
4. Discussion
Although several results suggest that the ¢nal step in GPI-
anchored protein synthesis is accomplished by a transamidase
[30^32], the cellular machinery involved in this GPI transami-
dase reaction is not yet de¢ned. It is di⁄cult to directly meas-
ure the activity of the transamidase in crude extracts [2]. Re-
cently, two components of the GPI transfer machinery have
been isolated from two yeast mutants gaa1 [23] and gpi8 [24]
both of which synthesize the complete GPI anchor precursor,
but do not attach it to proteins. Overexpression of the ¢rst of
these proteins Gaa1p (the subject of this study) enabled gaa1
mutant cells to GPI anchor proteins and improved their abil-
ity to attach anchors to nascent polypeptides of GPI-anchored
proteins with mutant anchor attachment sites [23].
In this study, we isolated a human homolog of yGaa1p by
the signal sequence trap method. This method is a unique
cloning strategy which uses NH2-terminal signal sequences.
With this method, not only secretory molecules, but also
ER or Golgi proteins containing NH2-terminal hydrophobic
sequences have been isolated [27]. In fact, we have isolated
many such proteins including interferon K/L receptor and sig-
nal sequence peptidase K in this way. A computer analysis
showed that hGaa1p has an NH2-terminal signal sequence
like that of yGaa1p.
The nucleotide sequence of hGAA1 showed no signi¢cant
homology with any known genes, but the deduced amino acid
sequence showed 28% homology with that of yeast Gaa1p.
hGAA1 cDNA has a long open reading frame with short 5P
and 3P untranslated regions. The putative translation initia-
tion site is fully consistent with the Kozak consensus and
there is a polyadenylation signal and a poly (A) tract at the
3P terminus. The size of the cDNA is almost the same as that
of the mRNA detected in Northern blot analysis (Fig. 3A). In
addition, the NH2-terminal sequences between hGaa1p and
yGaa1p are also highly conserved. We thus believe that we
have isolated cDNA sequence corresponding to full length
hGAA1 mRNA.
There are several consensus motifs in the deduced protein
of hGAA1. All of them are conserved in both human and
murine Gaa1p. The second phosphorylation site by protein
kinase C is homologous, threonine in human and serine in
murine, and other motifs are identical. Kite-Dolittle hydro-
phobicity analysis revealed that hGaa1p has eight putative
transmembrane domains, while yGaa1p has only six trans-
membrane domains. This di¡erence could be due to the pro-
gram algorithm, because some putative transmembrane do-
mains were assigned at di¡erent places by di¡erent analyses.
Both hGaa1p and yGaa1p have two putative N-glycosylation
sites. hGaa1p has seven protein kinase C phosphorylation
sites and yGaa1p has three sites. Only hGaa1p has a
cAMP- and cGMP-dependent protein kinase phosphorylation
site. These phosphorylation sites could be important for reg-
ulation of hGaa1p function.
hGAA1 mRNA is expressed ubiquitously in human fetus
and adult. The yeast gaa1 mutant cannot survive in normal
conditions [23] as GPI anchoring is indispensable for yeast but
apparently not for mammalian cells. In the course of develop-
ment, GAA1 mRNA expression levels are higher in the em-
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Fig. 5. Functional analysis of hGAA1 by overexpressing antisense hGAA1 cDNA. K562 cells transfected by the GPI-anchored reporter cDNA
without (upper two panels) or with antisense hGAA1 cDNA (lower two panels) were analyzed by FACS. Longitudial axis indicates the intensity
of propidium iodide staining and horizontal axis indicates the intensity of GPI anchored CD8 £uorescence, which re£ects the amount of GPI-
anchored reporter protein. Overexpression of antisense hGAA1 cDNA decreased the cell number of GPI-anchored CD8 £uorescence positive
cells presented in the right of threshold.
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bryonic stage than in the adult. In the rodent heart, mRNA is
abundant in the fetus and neonate, and it is low in the adult.
Moreover, in the in vitro di¡erentiation system of ES cells,
GAA1 mRNA levels decreased along with development.
Under di¡erentiation conditions, ES cells di¡erentiate into
many cell types and lose their proliferative ability. These re-
sults suggest that GPI anchoring is important in the early
di¡erentiating stage.
We examined the function of hGaa1p by overexpressing
antisense hGAA1 cDNA in human K562 cells. Although over-
expression of sense hGAA1 only slightly increased the produc-
tion of our GPI-anchored reporter protein, CD8-DAF, over-
expression of antisense hGAA1 cDNA signi¢cantly decreased
its production (Fig. 5, Table 1). These results suggest that
hGaa1p has functional activity that would be consistent
with that of yGaa1p. A hGPI8 mutant would be needed to
formally validate this proposal.
In summary, we have isolated a human homologue of
yGAA1 cDNA. Its protein product presumably is involved
in the transfer step of GPI anchor attachment to protein.
Its precise mechanism of action remains to be determined.
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